253 related articles for article (PubMed ID: 8043933)
1. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
2. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
[TBL] [Abstract][Full Text] [Related]
3. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
4. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
5. Monoclonal anti-D development programme.
Kumpel BM
Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
7. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
Shepard SL; Noble AL; Filbey D; Hadley AG
Vox Sang; 1996; 70(3):157-63. PubMed ID: 8740008
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
Rasteński J; Gryglicka M
Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
[No Abstract] [Full Text] [Related]
10. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus.
Gottvall T; Selbing A
Acta Obstet Gynecol Scand; 1995 Nov; 74(10):777-83. PubMed ID: 8533559
[TBL] [Abstract][Full Text] [Related]
11. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
Dooren MC; Engelfriet CP
Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
[TBL] [Abstract][Full Text] [Related]
12. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
Contreras M
Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
[No Abstract] [Full Text] [Related]
13. A major role of class I Fc gamma receptors in immunoglobulin G anti-D-mediated red blood cell destruction by fetal mononuclear phagocytes.
Wiener E; Mawas F; Dellow RA; Singh I; Rodeck CH
Obstet Gynecol; 1995 Aug; 86(2):157-62. PubMed ID: 7617343
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
15. [Changes in feto-maternal incompatibility and the indications for exchange transfusion].
Serrano J
Sangre (Barc); 1991 Dec; 36(6):471-6. PubMed ID: 1667442
[TBL] [Abstract][Full Text] [Related]
16. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
17. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
Pegoraro V; Urbinati D; Visser GHA; Di Renzo GC; Zipursky A; Stotler BA; Spitalnik SL
PLoS One; 2020; 15(7):e0235807. PubMed ID: 32687543
[TBL] [Abstract][Full Text] [Related]
19. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
Zavala C; Salamanca F
Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
